Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study.
暂无分享,去创建一个
T. Nickolas | F. Luft | B. Hahn | J. Giglio | E. Sherman | P. Devarajan | R. Kettritz | K. Schmidt-Ott | J. Barasch | S. Elitok | O. Maarouf | P. Canetta | M. Sise | A. Guddati | A. Geara | S. Saggi | A. Polland | C. Forster | M. O’Rourke | N. Malik | E. Singer | Antje Elger | S. Hebbar | Philip H. Imus | S. El‐Sayegh | D. S. Solá-Del Valle | Peter Lee | W. Rahman | Eugenia Singer | David Solá-Del Valle | Pietro Canetta | Abdallah Geara
[1] T. Nickolas,et al. Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. , 2011, Kidney international.
[2] R. Bellomo,et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. , 2011, Journal of the American College of Cardiology.
[3] J. Bakker,et al. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. , 2011, American journal of respiratory and critical care medicine.
[4] V. Jeevanandam,et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[5] C. Parikh,et al. Acute kidney injury: Defining prerenal azotemia in clinical practice and research , 2010, Nature Reviews Nephrology.
[6] Myung-Gyu Kim,et al. Urine Neutrophil Gelatinase-Associated Lipocalin: An Independent Predictor of Adverse Outcomes in Acute Kidney Injury , 2010, American Journal of Nephrology.
[7] Hui Geng,et al. Acute kidney injury: a springboard for progression in chronic kidney disease. , 2010, American journal of physiology. Renal physiology.
[8] S. Waikar,et al. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. , 2010, Kidney international.
[9] F. Grenier,et al. Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. , 2010, Clinical biochemistry.
[10] D. Fliser,et al. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury , 2010, Critical care.
[11] Rinaldo Bellomo,et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] R. Mehta,et al. Prerenal failure: from old concepts to new paradigms , 2009, Current opinion in critical care.
[13] L. Szczech. The development of urinary biomarkers for kidney disease is the search for our renal troponin. , 2009, Journal of the American Society of Nephrology : JASN.
[14] S. Waikar,et al. Creatinine kinetics and the definition of acute kidney injury. , 2009, Journal of the American Society of Nephrology : JASN.
[15] T. Nickolas,et al. Sensitivity and Specificity of a Single Emergency Department Measurement of Urinary Neutrophil GelatinaseAssociated Lipocalin for Diagnosing Acute Kidney Injury , 2008, Annals of Internal Medicine.
[16] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[17] P. Honore,et al. The early biomarker of acute kidney injury: in search of the Holy Grail , 2007, Intensive Care Medicine.
[18] C. McCulloch,et al. Community-based incidence of acute renal failure. , 2007, Kidney international.
[19] John A Kellum,et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.
[20] E. McCarthy,et al. Declining mortality in patients with acute renal failure, 1988 to 2002. , 2006, Journal of the American Society of Nephrology : JASN.
[21] Jonathan Himmelfarb,et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. , 2006, Journal of the American Society of Nephrology : JASN.
[22] Joseph V Bonventre,et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. , 2005, Journal of the American Society of Nephrology : JASN.
[23] M. Mitsnefes,et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. , 2003, Journal of the American Society of Nephrology : JASN.
[24] M. Yamanouchi,et al. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. , 2003, The Journal of laboratory and clinical medicine.
[25] S. Hou,et al. Hospital-acquired renal insufficiency. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[26] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[27] J Pascual,et al. Epidemiology of acute renal failure: A prospective, multicenter, community-based study , 1996 .
[28] N. Madias,et al. Serum creatinine as an index of renal function: new insights into old concepts. , 1992, Clinical chemistry.
[29] R. Star. Treatment of acute renal failure. , 1998, Kidney international.